Comparison between Bafna Pharmaceuticals IPO and Titagarh Wagons IPO.
Bafna Pharmaceuticals IPO is a Mainboard Bookbuilding IPO proposed to list at BSE while Titagarh Wagons IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Titagarh Wagons IPO is up to ₹128.72 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Titagarh Wagons IPO is ₹540.00 per share.
| Bafna Pharmaceuticals IPO | Titagarh Wagons IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹540.00 per share | |
| Issue Price (Upper) | ₹610.00 per share | |
| Issue Price (Final) | ₹40.00 per share | ₹540.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹0.00 per share | |
| Market Lot Size | 10 shares | |
| Fresh Issue Size | 64,00,206 shares | 20,68,111 shares |
| Fresh Issue Size (Amount) | up to ₹25.60 Cr | up to ₹111.68 Cr |
| OFS Issue Size | 0 shares | 3,15,657 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹17.05 Cr |
| Issue Size Total | 64,00,206 shares | 23,83,768 shares |
| Issue Size Total (Amount) | up to ₹25.60 Cr | up to ₹128.72 Cr |
Bafna Pharmaceuticals IPO opens on May 27, 2008, while Titagarh Wagons IPO opens on Mar 24, 2008. The closing date of Bafna Pharmaceuticals IPO and Titagarh Wagons IPO is May 30, 2008, and Mar 27, 2008, respectively.
| Bafna Pharmaceuticals IPO | Titagarh Wagons IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | May 27, 2008 | Mar 24, 2008 |
| Issue Close | May 30, 2008 | Mar 27, 2008 |
| Basis Of Allotment (Tentative) | ||
| Initiation of Refunds (Tentative) | ||
| Credit of Share (Tentative) | ||
| Listing date (Tentative) | Jun 27, 2008 | Apr 21, 2008 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Bafna Pharmaceuticals IPO P/E ratio is , as compared to Titagarh Wagons IPO P/E ratio of .
| Bafna Pharmaceuticals IPO | Titagarh Wagons IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 71.07 | 56.77 | ||||
| Promoter Shareholding (Post-Issue) | 42.6 | 49.25 | ||||
| P/E Ratio | ||||||
| Market Cap | ₹63.92 Cr. | ₹995.87 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ||||||
| RoNW | 10.65 | 28 |
In the Bafna Pharmaceuticals IPO Retail Individual Investors (RII) are offered 32,00,000 shares while in Titagarh Wagons IPO retail investors are offered 32,00,000 shares. Qualified Institutional Buyers (QIB) are offered in Bafna Pharmaceuticals IPO and 14,21,261 shares in Titagarh Wagons IPO.
| Bafna Pharmaceuticals IPO | Titagarh Wagons IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | ||
| QIB | 14,21,261 shares | |
| NII | 32,00,000 shares | 2,36,877 shares |
| RII | 32,00,000 shares | 7,10,630 shares |
| Employee | 15,000 shares | |
| Others | ||
| Total | 64,00,000 shares | 23,83,768 shares |
Bafna Pharmaceuticals IPO subscribed 4.88x in total, whereas Titagarh Wagons IPO subscribed 6.75x.
| Bafna Pharmaceuticals IPO | Titagarh Wagons IPO | |
|---|---|---|
| QIB (times) | 10.37x | |
| NII (times) | 1.57x | 2.77x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 8.20x | 0.98x |
| Employee (times) | 0.07x | |
| Other (times) | ||
| Total (times) | 4.88x | 6.75x |
